• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非心脏手术围手术期死亡率的国家风险预测模型。

National risk prediction model for perioperative mortality in non-cardiac surgery.

机构信息

Department of Anaesthesia and Perioperative Medicine, Auckland City Hospital, Auckland, New Zealand.

Orion Health, North Shore Hospital, Auckland, New Zealand.

出版信息

Br J Surg. 2019 Oct;106(11):1549-1557. doi: 10.1002/bjs.11232. Epub 2019 Aug 6.

DOI:10.1002/bjs.11232
PMID:31386174
Abstract

BACKGROUND

Many multivariable models to calculate mortality risk after surgery are limited by insufficient sample size at development or by application to cohorts distinct from derivation populations. The aims of this study were to validate the Surgical Outcome Risk Tool (SORT) for a New Zealand population and to develop an extended NZRISK model to calculate 1-month, 1-year and 2-year mortality after non-cardiac surgery.

METHODS

Data from the New Zealand National Minimum Data Set for patients having surgery between January 2013 and December 2014 were used to validate SORT. A random 75 per cent split of the data was used to develop the NZRISK model, which was validated in the other 25 per cent of the data set.

RESULTS

External validation of SORT in the 360 140 patients who underwent surgery in the study period showed good discrimination (area under the receiver operating characteristic curve (AUROC) value of 0·906) but poor calibration (McFadden's pseudo-R 0·137, calibration slope 5·32), indicating it was invalid in this national surgical population. Internal validation of the NZRISK model, which incorporates sex and ethnicity in addition to the variables used in SORT for 1-month, 1-year and 2-year outcomes, demonstrated excellent discrimination with AUROC values of 0·921, 0·904 and 0·895 respectively, and excellent calibration (McFadden's pseudo-R 0·275, 0·308 and 0·312 respectively). Calibration slopes were 1·12, 1·02 and 1·02 respectively.

CONCLUSION

The SORT performed poorly in this national population. However, inclusion of sex and ethnicity in the NZRISK model improved performance. Calculation of mortality risk beyond 30 days after surgery adds to the utility of this tool for shared decision-making.

摘要

背景

许多用于计算手术后死亡率的多变量模型存在发展过程中样本量不足或应用于与推导人群不同的队列的局限性。本研究的目的是验证新西兰人群的外科手术风险工具(SORT),并开发一种扩展的 NZRISK 模型来计算非心脏手术后 1 个月、1 年和 2 年的死亡率。

方法

使用新西兰国家最低数据集(New Zealand National Minimum Data Set)中 2013 年 1 月至 2014 年 12 月期间接受手术的患者的数据来验证 SORT。数据集的 75%随机分割用于开发 NZRISK 模型,然后在数据集的其余 25%中验证该模型。

结果

在研究期间接受手术的 360140 例患者中对 SORT 进行外部验证表明,该模型具有良好的区分度(接受者操作特征曲线下面积(area under the receiver operating characteristic curve, AUROC)值为 0.906),但校准效果较差(McFadden 伪 R 为 0.137,校准斜率为 5.32),表明该模型在这个全国性的手术人群中是无效的。对 NZRISK 模型的内部验证,该模型除了在 SORT 中用于 1 个月、1 年和 2 年结果的变量外,还纳入了性别和种族,结果显示其具有极好的区分度,AUROC 值分别为 0.921、0.904 和 0.895,且校准效果极好(McFadden 伪 R 分别为 0.275、0.308 和 0.312)。校准斜率分别为 1.12、1.02 和 1.02。

结论

SORT 在这个全国性人群中的表现不佳。然而,在 NZRISK 模型中纳入性别和种族可以提高模型的性能。计算手术后 30 天以上的死亡率增加了该工具在共同决策中的效用。

相似文献

1
National risk prediction model for perioperative mortality in non-cardiac surgery.非心脏手术围手术期死亡率的国家风险预测模型。
Br J Surg. 2019 Oct;106(11):1549-1557. doi: 10.1002/bjs.11232. Epub 2019 Aug 6.
2
Editor's Choice - Development and Validation of a Multivariable Prediction Model of Peri-operative Mortality in Vascular Surgery: The New Zealand Vascular Surgical Risk Tool (NZRISK-VASC).编辑精选 - 血管外科学围手术期死亡率的多变量预测模型的制定与验证:新西兰血管外科学风险工具 (NZRISK-VASC)。
Eur J Vasc Endovasc Surg. 2021 Apr;61(4):657-663. doi: 10.1016/j.ejvs.2020.12.008. Epub 2021 Jan 8.
3
Development and Validation of a Multivariate Prediction Model of Perioperative Mortality in Neurosurgery: The New Zealand Neurosurgical Risk Tool (NZRISK-NEURO).新西兰神经外科风险工具(NZRISK-NEURO):一种用于预测神经外科围手术期死亡率的多变量预测模型的开发和验证。
Neurosurgery. 2020 Sep 1;87(3):E313-E320. doi: 10.1093/neuros/nyaa144.
4
Development and validation of a national perioperative mortality risk model for pediatric surgery: The New Zealand pediatric surgical risk tool (NZRISK-pediatric): NZRISK-Pediatric.开发和验证新西兰小儿外科围手术期死亡率风险模型:新西兰小儿外科风险工具(NZRISK-pediatric):NZRISK-Pediatric。
J Pediatr Surg. 2023 Mar;58(3):524-531. doi: 10.1016/j.jpedsurg.2022.07.017. Epub 2022 Jul 28.
5
Temporal validation of a multivariable surgical mortality prediction model (NZRisk): a New Zealand national cohort study.多变量手术死亡率预测模型(NZRisk)的时间验证:新西兰全国队列研究。
BMJ Open. 2023 Mar 30;13(3):e069911. doi: 10.1136/bmjopen-2022-069911.
6
Developing and validating subjective and objective risk-assessment measures for predicting mortality after major surgery: An international prospective cohort study.开发和验证用于预测大手术后死亡率的主观和客观风险评估措施:一项国际前瞻性队列研究。
PLoS Med. 2020 Oct 15;17(10):e1003253. doi: 10.1371/journal.pmed.1003253. eCollection 2020 Oct.
7
Development and validation of the Surgical Outcome Risk Tool (SORT).外科手术结果风险工具(SORT)的开发与验证
Br J Surg. 2014 Dec;101(13):1774-83. doi: 10.1002/bjs.9638.
8
Few and feasible preoperative variables can identify high-risk surgical patients: derivation and validation of the Ex-Care risk model.少数可行的术前变量可识别高风险手术患者:Ex-Care 风险模型的推导和验证。
Br J Anaesth. 2021 Feb;126(2):525-532. doi: 10.1016/j.bja.2020.09.036. Epub 2020 Oct 27.
9
Surgical Outcome Risk Tool (SORT) to predict 30-day postoperative mortality in a mixed surgical population in Swedish tertiary hospitals.SORT(手术结局风险工具)预测瑞典三级医院混合外科人群 30 天术后死亡率。
Br J Surg. 2023 Apr 12;110(5):584-590. doi: 10.1093/bjs/znad039.
10
Assessment of the EuroSCORE II in a New Zealand Tertiary Centre.新西兰一家三级医疗中心的 EuroSCORE II 评估。
Heart Lung Circ. 2019 Nov;28(11):1670-1676. doi: 10.1016/j.hlc.2018.09.004. Epub 2018 Sep 27.

引用本文的文献

1
Inequities in 'failure to rescue' for Indigenous Māori after gastrointestinal cancer surgery in New Zealand.新西兰毛利族胃肠道癌手术后“未能挽救”情况中的不平等现象。
Br J Surg. 2025 Aug 1;112(8). doi: 10.1093/bjs/znaf161.
2
Using Days Alive and Out of Hospital to measure inequities and explore pathways through which inequities emerge after coronary artery bypass grafting in Aotearoa New Zealand: a secondary data analysis using a retrospective cohort.利用存活天数和出院情况来衡量新西兰奥特亚罗瓦冠状动脉搭桥术后的不平等现象,并探索不平等现象出现的途径:一项使用回顾性队列的二次数据分析。
BMJ Open. 2025 Feb 3;15(2):e093479. doi: 10.1136/bmjopen-2024-093479.
3
Study protocol of the PRINCESS trial-PReoperative INtermittent fasting versus CarbohydratE loading to reduce inSulin resiStance versus standard of care in orthopaedic patients: a randomised controlled trial.
PRINCESS试验方案——骨科患者术前间歇性禁食与碳水化合物负荷以降低胰岛素抵抗对比标准护理:一项随机对照试验
BMJ Open. 2025 Jan 21;15(1):e087260. doi: 10.1136/bmjopen-2024-087260.
4
An interrater reliability analysis of preoperative mortality risk calculators used for elective high-risk noncardiac surgical patients shows poor to moderate reliability.用于择期高危非心脏手术患者的术前死亡率计算器的组内可靠性分析显示,可靠性差至中等。
BMC Anesthesiol. 2024 Oct 30;24(1):392. doi: 10.1186/s12871-024-02771-8.
5
Lessons learned from developing a COVID-19 algorithm governance framework in Aotearoa New Zealand.从新西兰制定新冠病毒算法治理框架中吸取的经验教训。
J R Soc N Z. 2022 Sep 19;53(1):82-94. doi: 10.1080/03036758.2022.2121290. eCollection 2023.
6
Development and validation of 'Patient Optimizer' (POP) algorithms for predicting surgical risk with machine learning.用于通过机器学习预测手术风险的“患者优化器”(POP)算法的开发与验证
BMC Med Inform Decis Mak. 2024 Mar 11;24(1):70. doi: 10.1186/s12911-024-02463-w.
7
Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study.主要下肢截肢后长期风险预测:PERCEIVE 研究的 1 年结果。
BJS Open. 2024 Jan 3;8(1). doi: 10.1093/bjsopen/zrad135.
8
AntiPORT: adaptation of a transfusion prediction score to an Australian cardiac surgery population.AntiPORT:将输血预测评分应用于澳大利亚心脏手术人群
Crit Care Resusc. 2023 Oct 16;24(4):360-368. doi: 10.51893/2022.4.OA6. eCollection 2022 Dec 5.
9
External validity of four risk scores predicting 30-day mortality after surgery.四种预测术后30天死亡率的风险评分的外部效度
BJA Open. 2022 Jun 23;3:100018. doi: 10.1016/j.bjao.2022.100018. eCollection 2022 Sep.
10
Using Days Alive and Out of Hospital to measure inequities and possible pathways for them after cardiovascular surgery in Aotearoa New Zealand: study protocol for a secondary data analysis.使用存活日数和出院后天数衡量新西兰心血管手术后的不平等及其可能途径:二次数据分析研究方案。
BMJ Open. 2023 Jul 30;13(7):e066876. doi: 10.1136/bmjopen-2022-066876.